AVNS - Company ID 0001606498
AVANOS MEDICAL, INC. (AVNS) reported revenue of $701.20M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $701.20M | +1.9% |
| FY 2024 | $687.80M | +2.2% |
| FY 2023 | $673.30M | -1.6% |
| FY 2022 | $684.10M | +16.5% |
| FY 2021 | $587.00M | -17.9% |
| FY 2020 | $714.80M | +2.5% |
| FY 2019 | $697.60M | +6.9% |
| FY 2018 | $652.30M | +6.7% |
| FY 2017 |
AVANOS MEDICAL, INC. (AVNS) reported revenue of $701.20M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, AVANOS MEDICAL, INC.'s revenue declined from $1.68B to $701.20M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $611.60M |
| +8.0% |
| FY 2016 | $566.20M | +11.2% |
| FY 2015 | $509.00M | -69.6% |
| FY 2014 | $1.67B | -0.3% |
| FY 2013 | $1.68B | -0.4% |
| FY 2012 | $1.68B | - |